Q32 Bio Inc. - Common Stock QTTB 深 滬
已收盤 12-12 16:00:00 美东时间
2.96
-0.220
-6.92%
華盛通- 最 高3.27
- 今 開3.16
- 成交量 32.91万股
- 最 低 2.85
- 昨 收 3.18
- 總市值 3610.49万
- 52周最高 6.3699
- 市盈率 靜 --
- 換手率 2.70%
- 52周最低 1.345
- 委 比 -31.15%
- 總股本 1219.76万
- 歷史最高 572.40
- 量 比 0.69
- 振 幅 13.21%
- 歷史最低 1.345
- 每 手 1
- 風險率 0.72%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Is Small-Cap Q32 Bio Stock Soaring On Monday?
Q32 Bio shares rise after selling ADX-097 to Akebia in a deal worth up to $592 million, boosting cash runway into late 2027.
12-01 22:43
Market-Moving News for December 1st
QTTB: 97% | Q32 Bio Sells Phase 2 Complement Inhibitor ADX-097 To Akebia Therapeutics For $12M Upfront Payment; Co. Eligible To receive Up To $592M In Milestones As Well As Royalties DYAI: 35% | Dyadic
12-01 20:37
Akebia Therapeutics Establishes Rare Kidney Disease Pipeline With AKB-097 Acquisition From Q32 Bio And Praliciguat Candidate
Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 BioPhase 2 basket trial planned to evaluate complement inhibitor in multiple rare kidney disease indicationsPhase 2 trial
12-01 20:09
Q32 Bio Sells Complement Inhibitor ADX-097
-- Asset sale further enables Company's strategic focus on advancing bempikibart for alopecia areata -- -- $12 million in upfront and guaranteed near-term milestone payments expected to exte...
12-01 20:00
Q32 Bio Q3 EPS $(0.60) Beats $(0.99) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.99) by 39.39 percent. This is a 58.9 percent increase over losses of $(1.46) per share from the same
11-13 20:01
Q32 Bio Completes Enrollment In Part B Of SIGNAL-AA Phase 2a Clinical Trial Evaluating Bempikibart In Patients With Severe Or Very Severe AA
-- SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients --WALTHAM, Mass., Oct. 21, 2025 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ:QTTB) ("Q32 Bio"), a clinical stage
10-21 19:13
美联储降息再迎大消息，纳指生科创年内新高，纳指生物科技ETF(513290)强势收涨6.22%，连续16日获资金加仓，“吸金”近7300万元
隔夜（10月8日）美股收盘，美股三大指数涨跌不一，纳指涨1.12%，标普500指数涨0.58%，两者均创收盘新高，道指收平。纳斯达克生物科技指数收涨0.89%...
10-09 17:58
美联储降息再迎大消息，纳指生科年内新高，纳指生物科技ETF涨6.22%
（来源：指能添富） 同花顺ETF大赛火热进行中，奖品有华为双折叠和宇树机器狗，也可以去抄一抄作业～#ETF大赛# 隔夜（10月8日）美股收盘，美股三大...
10-09 17:53
Q32 Bio Q2 EPS $(0.78) Beats $(1.29) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(1.29) by 39.53 percent. This is a 45.07 percent increase over losses of $(1.42) per share from the same
08-06 20:37
Q32 Bio GAAP EPS of -$0.78
Q32 Bio press release (NASDAQ:QTTB): Q2 GAAP EPS of -$0.78. Cash and cash equivalents were $54.8 million as of June 30, 2025. Q32 Bio believes its cash and cash equivalents are sufficient to fund oper...
08-06 19:45
